Ellis J, Hoss W
Biochem Pharmacol. 1982 Mar 1;31(5):873-6. doi: 10.1016/0006-2952(82)90477-4.
Gallamine, a cholinergic antagonist at the (nicotinic) neuromuscular junction possesses antimuscarinic potency in several systems. We report here that gallamine inhibited the binding of [3H] quinuclidinyl benzilate (QNB) in a competitive manner in the brainstem and forebrain of the rat. The occupancy curves derived from these studies suggest that gallamine has widely varying affinities for different subpopulations of muscarinic receptors, a finding which sets gallamine apart from classical muscarinic antagonists such as atropine and QNB. The greatest difference in affinities for gallamine occurred in the brainstem, where the data could be satisfactorily fitted to a two-site model, with 77% of the receptors having high affinity (Kd = 25 nM) and 23% low affinity (93 microM). Further, these affinities displayed rank order correlation with those of carbachol (an agonist), although gallamine has not, so far, displayed agonist (or partial agonist) activity. The finding that antagonists as well as agonists can display multiple affinities for muscarinic receptors suggests that there are fundamental differences among subpopulations of these receptors.
加拉明是一种作用于(烟碱型)神经肌肉接头的胆碱能拮抗剂,在多个系统中具有抗毒蕈碱活性。我们在此报告,加拉明在大鼠脑干和前脑以竞争性方式抑制[³H]喹核醇基苯甲酸酯(QNB)的结合。从这些研究得出的占据曲线表明,加拉明对不同亚群的毒蕈碱受体具有广泛不同的亲和力,这一发现使加拉明有别于经典的毒蕈碱拮抗剂如阿托品和QNB。加拉明亲和力的最大差异出现在脑干,在那里数据可以令人满意地拟合到一个双位点模型,其中77%的受体具有高亲和力(Kd = 25 nM),23%具有低亲和力(93 μM)。此外,尽管加拉明迄今为止尚未表现出激动剂(或部分激动剂)活性,但其这些亲和力与卡巴胆碱(一种激动剂)的亲和力呈等级顺序相关。拮抗剂以及激动剂对毒蕈碱受体可表现出多种亲和力这一发现表明,这些受体的亚群之间存在根本差异。